U.S. Department of Health & Human Services Divider Arrow National Institutes of Health Divider Arrow NCATS

Approval Year

Unknown
139594
Substance Class
Concept
Record UNII
YB18NF020M
Record Status non-approved
Record Version
  • Download
Name Type Language
SATRALIZUMAB-MWGE
FDA  
Preferred Name English
ENSPRYNG
Brand Name English
Satralizumab mwge [WHO-DD]
Common Name English
Classification Tree Code System Code
FDA ORPHAN DRUG 802720
Created by admin on Sat Dec 16 17:28:22 UTC 2023 , Edited by admin on Sat Dec 16 17:28:22 UTC 2023
FDA ORPHAN DRUG 824521
Created by admin on Sat Dec 16 17:28:22 UTC 2023 , Edited by admin on Sat Dec 16 17:28:22 UTC 2023
FDA ORPHAN DRUG 822921
Created by admin on Sat Dec 16 17:28:22 UTC 2023 , Edited by admin on Sat Dec 16 17:28:22 UTC 2023
Code System Code Type Description
BIOLOGIC SUBSTANCE CLASSIFICATION CODE
YB18NF020M-MWGE-01
Created by admin on Sat Dec 16 17:28:22 UTC 2023 , Edited by admin on Sat Dec 16 17:28:22 UTC 2023
PRIMARY
This is a sub-concept of substance:
SATRALIZUMAB
Related Record Type Details
SATRALIZUMAB
SUBSTANCE -> SUB_CONCEPT
This is a sub-concept of substance:
SATRALIZUMAB
NIH
NCATS
PRIVACY ACT
ACCESSIBILITY
DISCLAIMER
HHS VULNERABILITY DISCLOSURE
For language access assistance, contact the NCATS Public Information Officer
National Center for Advancing Translational Sciences (NCATS),
6701 Democracy Boulevard, Bethesda MD 20892-4874 • 301-594-8966